APA-referens (7:e uppl.)

Jin, Y., Liu, Q., Sun, B., Li, X., Wu, J., Lin, Z., . . . Jia, H. (2024). Pralatrexate represses the resistance of HCC cells to molecular targeted agents via the miRNA-34a/Notch pathway. Discover Oncology, 15(1), 1. https://doi.org/10.1007/s12672-024-01572-2

Chicago-referens (17:e uppl.)

Jin, Yang, Qiming Liu, Baisheng Sun, Xiaokang Li, Jiahao Wu, Zhiyuan Lin, Yan Ma, och Haijiang Jia. "Pralatrexate Represses the Resistance of HCC Cells to Molecular Targeted Agents via the MiRNA-34a/Notch Pathway." Discover Oncology 15, no. 1 (2024): 1. https://doi.org/10.1007/s12672-024-01572-2.

MLA-referens (9:e uppl.)

Jin, Yang, et al. "Pralatrexate Represses the Resistance of HCC Cells to Molecular Targeted Agents via the MiRNA-34a/Notch Pathway." Discover Oncology, vol. 15, no. 1, 2024, p. 1, https://doi.org/10.1007/s12672-024-01572-2.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.